Johnson and Johnson COVID Vaccine on ‘Pause’ After FDA, CDC Report Rare Blood Clot Issues

The Biden administration called for a ‘pause’ in administering the Johnson and Johnson COVID-19 China coronavirus vaccine Tuesday morning. The FDA and CDC, citing six reports of blood clots in women aged 18-48–including one fatality–out of about seven million administered vaccines, called on states to ‘pause’ the J&J vaccine while the problem is studied. The … Continue reading Johnson and Johnson COVID Vaccine on ‘Pause’ After FDA, CDC Report Rare Blood Clot Issues